The Japan synthetic biology market is estimated to grow from USD 0.79 billion in the current year to USD 5.74 billion by 2040 at a CAGR of 15.7% during the forecast period, 2026-2040.
Notably, Japan holds a prominent position in the Asia-Pacific synthetic biology market due to its advanced R&D ecosystem and strategic investments. In addition, several factors contribute to higher market share compared to other regions . Further, health-conscious consumers are driving the demand for sustainable bio-products, such as personalized medicines and eco-materials, amplified by Japan's manufacturing strength and trade partnerships. These elements position Japan as a mature hub amid demographic and cost challenges.
Genomatica has successfully developed a microorganism-based production method (Geno proprietary technology) that transforms renewable sugars from plants into precursors for nylon (100% renewable carbon-sourced nylon-6). The agriculture sector has also seen a rising implementation of synthetic biology for research and development purposes. For instance, Rice University established the Rice Synthetic Biology Institute to foster collaborative research in synthetic biology and translate it into advantageous technologies.
Alongside the increased utilization of synthetic biology in various fields, the high demand for early disease detection and treatment is propelling research and development in advanced genetic technologies. It is worth highlighting that the growing focus on cancer treatment research has promoted the use of synthetic biology. This technology is instrumental in producing enabling products, including glutaminase, arginase, oxidase, dehydrogenase, deiminase, and ribonuclease, which serve as essential components in the evaluation of cancer-causing cells and in the creation of therapies. Given these trends, we anticipate that the synthetic biology market will experience substantial growth throughout the forecast period.
JAPAN SYNTHETIC BIOLOGY MARKET: GROWTH AND TRENDS
Synthetic biology refers to biological systems that are deliberately designed using various molecular technologies and tools to create medicines and other bio-based products. The synthetic biology sector is witnessing notable growth spurred by the increasing adoption of targeted therapies, biologics and biology-derived products. This field allows for the development of custom-engineered organisms, enabling pharmaceutical companies to design vaccines, semi-synthetic drugs, and gain insights into disease mechanisms. Besides pharmaceuticals, there is a noteworthy rise in the interest for synthetic biology in the biotechnology sector, agriculture, and environmental applications. Moreover, the ongoing shift towards biofuels or green fuels and the demand for sustainable or biodegradable products have further fueled market expansion. As synthetic biology technologies mature across various industrial sectors, they are paving the way for the production of sustainable bio-based solutions. In addition, advancements in synthetic biology are broadening their applications as tools for writing, reading, and editing DNA in organisms to produce valuable commodities.Notably, Japan holds a prominent position in the Asia-Pacific synthetic biology market due to its advanced R&D ecosystem and strategic investments. In addition, several factors contribute to higher market share compared to other regions . Further, health-conscious consumers are driving the demand for sustainable bio-products, such as personalized medicines and eco-materials, amplified by Japan's manufacturing strength and trade partnerships. These elements position Japan as a mature hub amid demographic and cost challenges.
Genomatica has successfully developed a microorganism-based production method (Geno proprietary technology) that transforms renewable sugars from plants into precursors for nylon (100% renewable carbon-sourced nylon-6). The agriculture sector has also seen a rising implementation of synthetic biology for research and development purposes. For instance, Rice University established the Rice Synthetic Biology Institute to foster collaborative research in synthetic biology and translate it into advantageous technologies.
Alongside the increased utilization of synthetic biology in various fields, the high demand for early disease detection and treatment is propelling research and development in advanced genetic technologies. It is worth highlighting that the growing focus on cancer treatment research has promoted the use of synthetic biology. This technology is instrumental in producing enabling products, including glutaminase, arginase, oxidase, dehydrogenase, deiminase, and ribonuclease, which serve as essential components in the evaluation of cancer-causing cells and in the creation of therapies. Given these trends, we anticipate that the synthetic biology market will experience substantial growth throughout the forecast period.
Growth Drivers: Strategic Enablers of Market Expansion
Advancements in CRISPR technology and DNA synthesis are decreasing costs and enhancing accuracy in biological engineering. There is a rising need for bio-derived fuels, materials, and therapeutics as part of decarbonization initiatives, backed by robust academic research and global collaborations. Government regulations and Japan's proficiency in precision engineering are also driving the adoption in the healthcare and manufacturing sectors.Market Challenges: Critical Barriers Impeding Progress
The expensive nature of platforms and bioprocessing obstructs scaling up, especially for intricate therapies. Regulatory challenges concerning engineered organisms, along with ethical and biosafety issues, delay the arrival of products to the market. A lack of skilled talent in various fields and pushback from conventional industries create obstacles for broader adoption of synthetic Biology in Japan.Polymerase Chain Reaction (PCR): Leading Market Segment
In terms of type of technology, the Japan synthetic biology market is segmented across PCR Technology, NGS technology, genome editing technology, bioprocessing technology and other technologies. Currently, polymerase chain reaction (PCR) segment captures around 30% of the overall market share, due to its precision, rapidity, and extensive use in identifying infectious diseases, genetic conditions, and cancer. However, the genome editing technology segment is likely to grow at a higher CAGR of 16.6% during the forecast period, which is probably influenced by its capacity to deliver detailed genomic data and sophisticated personalized medical care.Oligonucleotide / Oligo Pools and Synthetic DNA: Dominating Market Segment
In terms of type of product, the Japan synthetic biology market is segmented across oligonucleotide / oligo pools and synthetic DNAdna, enzymes, cloning technologies kits, chassis organism, and others. Currently, majority (~30%) of the market share is held by oligonucleotide / oligo pools and synthetic DNA. This can be linked to the collection of blood, serum, and plasma in clinical environments, which facilitates large-scale testing and ongoing observation. Additionally, the urine segment is expected to experience a higher compound annual growth rate (CAGR) of 7.1% throughout the forecast period.Academic and Government Research Institutes: Emerging Market Segment
In terms of end-users, the Japan synthetic biology market is segmented across biotechnology and pharmaceutical companies, academic and government research institutes and others. Currently, majority (~70%) of the market share is held by biotechnology and pharmaceutical companies. However, Academic and Government Research Institutes are anticipated to grow at a higher CAGR of 16.1%.JAPAN SYNTHETIC BIOLOGY MARKET: KEY SEGMENTS
Type of Product
- Core Products
- Enabling Products
Type of Tool
- Oligonucleotides and Synthetic DNA
- Enzymes
- Cloning Technology Kits
- Synthetic Cells
Type of Technology
- Gene Synthesis
- Genome Engineering
- Microfluidics
- Nanotechnology
- Sequencing
- Bioinformatics
- Site-Directed Mutagenesis
- Cloning
- Measurement and Modeling
- Polymerase Chain Reaction
Type of Application
- Healthcare
- Artificial Tissue & Tissue Regeneration
- Industrial
- Environmental
- Food
- Agriculture
End User
- Biotechnology and Pharmaceutical companies
- Academic and Research Institutes
- Other End Users
KEY QUESTIONS ANSWERED IN THIS REPORT
- How many synthetic biology solution providers are currently engaged in this market?
- Which are the leading companies in this market?
- Which country dominates the Japan synthetic biology market?
- What are the key trends observed in the Japan synthetic biology market?
- What factors are likely to influence the evolution of this market?
- What are the primary challenges faced by synthetic biology solution providers in Japan?
- What is the current and future Japan synthetic biology market size?
- What is the CAGR of Japan synthetic biology market?
- How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
- The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
- The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
- The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
- The report allows for more effective communication with the audience and in building strong business relations.
COMPLEMENTARY BENEFITS
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with the Research Team
- Free Updated report if the report is 6-12 months old or older
Table of Contents
1. PREFACE
2. RESEARCH METHODOLOGY
3. MARKET DYNAMICS
4. MACRO-ECONOMIC INDICATORS
6. INTRODUCTION
7. MARKET LANDSCAPE
8. COMPANY COMPETITIVENESS ANALYSIS
9. COMPANY PROFILES: JAPAN SYNTHETIC BIOLOGY MARKET
10. PARTNERSHIPS AND COLLABORATIONS
11. MARKET IMPACT ANALYSIS
12. JAPAN SYNTHETIC BIOLOGY MARKET
13. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF PRODUCT
14. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF TOOL
15. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF TECHNOLOGY
16. JAPAN SYNTHETIC BIOLOGY MARKET, BY TYPE OF APPLICATION
17. JAPAN SYNTHETIC BIOLOGY MARKET, BY END USERS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amyris
- Bruker Cellular Analysis
- BICO
- Codexis
- Ginkgo Bioworks Holdings
- GenScript Biotech
- Integrated DNA Technologies
- Insitro
- Novozymes
- Pivot Bio
- Twist Bioscience
- Viridos
- Zymergen (Acquired by Ginkgo Bioworks)
Methodology
LOADING...
